Colgate-Palmolive (NYSE: CL) reported Q2 EPS of $0.92, $0.02 better than the analyst estimate of $0.90. Revenue for the quarter came in at $5.11 billion versus the consensus estimate of $5.03 billion.

GUIDANCE

Full Year 2025 Guidance

Based on current spot rates and including the estimated impact of tariffs announced and finalized as of July 31, 2025:

The Company still expects net sales to be up low single digits, now including a flat to low-single-digit negative impact from foreign exchange.
The Company now expects organic sales growth to be at the low end of 2% to 4%, including the impact over the course of 2025 of the planned exit from private label pet sales.
On a GAAP basis, the Company still expects both gross profit margin and advertising investment to be roughly flat as a percentage of net sales, and earnings per share to be up low single digits.
On a non-GAAP (Base Business) basis, the Company still expects both gross profit margin and advertising to be roughly flat as a percentage of net sales, and earnings per share to be up low single digits.

For earnings history and earnings-related data on Colgate-Palmolive (CL) click here.